Literature DB >> 18632629

Pten deficiency in melanocytes results in resistance to hair graying and susceptibility to carcinogen-induced melanomagenesis.

Tae Inoue-Narita1, Koichi Hamada, Takehiko Sasaki, Sachiko Hatakeyama, Sachiko Fujita, Kohichi Kawahara, Masato Sasaki, Hiroyuki Kishimoto, Satoshi Eguchi, Itaru Kojima, Friedrich Beermann, Tetsunori Kimura, Masatake Osawa, Satoshi Itami, Tak Wah Mak, Toru Nakano, Motomu Manabe, Akira Suzuki.   

Abstract

Phosphate and tensin homologue deleted on chromosome 10 (PTEN) is a tumor suppressor gene inactivated in numerous sporadic cancers, including melanomas. To analyze Pten functions in melanocytes, we used the Cre-loxP system to delete Pten specifically in murine pigment-producing cells and generated DctCrePten(flox/flox) mice. Half of DctCrePten(flox/flox) mice died shortly after birth with enlargements of the cerebral cortex and hippocampus. Melanocytes were increased in the dermis of perinatal DctCrePten(flox/flox) mice. When the mutants were subjected to repeated depilations, melanocyte stem cells in the bulge of the hair follicle resisted exhaustion and the mice were protected against hair graying. Although spontaneous melanomas did not form in DctCrePten(flox/flox) mice, large nevi and melanomas developed after carcinogen exposure. DctCrePten(flox/flox) melanocytes were increased in size and exhibited heightened activation of Akt and extracellular signal-regulated kinases, increased expression of Bcl-2, and decreased expression of p27(Kip1). Our results show that Pten is important for the maintenance of melanocyte stem cells and the suppression of melanomagenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18632629     DOI: 10.1158/0008-5472.CAN-08-0889

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

Review 1.  Genetic alterations of PTEN in human melanoma.

Authors:  Almass-Houd Aguissa-Touré; Gang Li
Journal:  Cell Mol Life Sci       Date:  2011-11-11       Impact factor: 9.261

2.  Targeted delivery of NRASQ61R and Cre-recombinase to post-natal melanocytes induces melanoma in Ink4a/Arflox/lox mice.

Authors:  Matthew W VanBrocklin; James P Robinson; Kristin J Lastwika; Joseph D Khoury; Sheri L Holmen
Journal:  Pigment Cell Melanoma Res       Date:  2010-04-23       Impact factor: 4.693

Review 3.  A family business: stem cell progeny join the niche to regulate homeostasis.

Authors:  Ya-Chieh Hsu; Elaine Fuchs
Journal:  Nat Rev Mol Cell Biol       Date:  2012-01-23       Impact factor: 94.444

4.  Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11.

Authors:  Masato Sasaki; Kohichi Kawahara; Miki Nishio; Koshi Mimori; Ryunosuke Kogo; Koichi Hamada; Bunsho Itoh; Jia Wang; Yukako Komatsu; Yong Ryoul Yang; Hiroki Hikasa; Yasuo Horie; Takayuki Yamashita; Takehiko Kamijo; Yanping Zhang; Yan Zhu; Carol Prives; Toru Nakano; Tak Wah Mak; Takehiko Sasaki; Tomohiko Maehama; Masaki Mori; Akira Suzuki
Journal:  Nat Med       Date:  2011-07-31       Impact factor: 53.440

Review 5.  PTEN loss in the continuum of common cancers, rare syndromes and mouse models.

Authors:  M Christine Hollander; Gideon M Blumenthal; Phillip A Dennis
Journal:  Nat Rev Cancer       Date:  2011-04       Impact factor: 60.716

Review 6.  Using genetics and genomics strategies to personalize therapy for cancer: focus on melanoma.

Authors:  Katherine L Nathanson
Journal:  Biochem Pharmacol       Date:  2010-04-20       Impact factor: 5.858

7.  Skeletal muscle phenotypically converts and selectively inhibits metastatic cells in mice.

Authors:  Ara Parlakian; Iman Gomaa; Sounkary Solly; Ludovic Arandel; Alka Mahale; Gustav Born; Giovanna Marazzi; David Sassoon
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

Review 8.  PTEN, stem cells, and cancer stem cells.

Authors:  Reginald Hill; Hong Wu
Journal:  J Biol Chem       Date:  2008-12-30       Impact factor: 5.157

9.  Characterization of melanoma cells capable of propagating tumors from a single cell.

Authors:  Matthew A Held; David P Curley; David Dankort; Martin McMahon; Viswanathan Muthusamy; Marcus W Bosenberg
Journal:  Cancer Res       Date:  2010-01-01       Impact factor: 12.701

10.  Braf(V600E) cooperates with Pten loss to induce metastatic melanoma.

Authors:  David Dankort; David P Curley; Robert A Cartlidge; Betsy Nelson; Anthony N Karnezis; William E Damsky; Mingjian J You; Ronald A DePinho; Martin McMahon; Marcus Bosenberg
Journal:  Nat Genet       Date:  2009-03-12       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.